Skip To Main Content

Inspiration and Innovation

Get inspired and stay on the cutting edge of innovation with these resources.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
What Are the Signs and Symptoms of ASMD?

What Are the Signs and Symptoms of ASMD?

An Evidence about The Role of Basal Insulin Glargine 300 U/mL Post-GLP-1 Therapy

An Evidence about The Role of Basal Insulin Glargine 300 U/mL Post-GLP-1 Therapy

Prospective evaluation of lipid management following ACS in Saudi Arabia (ACOSYM Study)

Prospective evaluation of lipid management following ACS in Saudi Arabia (ACOSYM Study)

Advancing Therapy with iGlarLixi: Differentiation from other complex regimens

Advancing Therapy with iGlarLixi: Differentiation from other complex regimens

Acute LDL-C Reduction Post ACS: Strike Early and Strike Strong: From Evidence to Clinical Practice

Acute LDL-C Reduction Post ACS: Strike Early and Strike Strong: From Evidence to Clinical Practice

Treatment simplification of complex insulin regimens in T2D

Treatment simplification of complex insulin regimens in T2D

Insulin advancement in Type 2 diabetes: Unmet needs with commonly-used options

Insulin advancement in Type 2 diabetes: Unmet needs with commonly-used options

Glargine 300 use in people with type 2 diabetes who fast during Ramadan

Glargine 300 use in people with type 2 diabetes who fast during Ramadan

Gaucher

Gaucher

Challenges associated with commonly-used insulin advancement options

Challenges associated with commonly-used insulin advancement options

Better care for Fabry

Better care for Fabry

Every Moment Matters on the Fabry Journey

EVOLUTION: RWE from Saudi Arabia

EVOLUTION: RWE from Saudi Arabia